SentryDx
医疗和诊断实验室
White Bear Lake,Minnesota 47 位关注者
Accurately diagnosing residual cancer from a blood draw
关于我们
NexGen accurately detects cancer DNA from a simple blood draw (liquid biopsy). Cancer DNA is rare, but NexGen's technology makes detection easy. NexGen takes a blood sample and replicates the DNA, like PCR, but adds a blocker to prevent normal DNA from replicating. This allows for the enrichment and easy detection of cancer DNA. Liquid biopsies can detect cancer up to 16 months before the current standard, which is radiological imaging. Early detection will lead to better treatment and saves millions of lives. NexGen's goal is to receive FDA approval for diagnosing cancer from a blood draw and is uniquely positions, compared to many competitors, to meet the FDA's guidance on in vitro diagnostic regulation.
- 网站
-
https://sentrydx.com/
SentryDx的外部链接
- 所属行业
- 医疗和诊断实验室
- 规模
- 2-10 人
- 总部
- White Bear Lake,Minnesota
- 类型
- 合营企业
- 创立
- 2021
地点
-
主要
1793 Buerkle Circle
US,Minnesota,White Bear Lake,55110